Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

被引:32
|
作者
Schilder, C. M. T. [1 ]
Seynaeve, C. [2 ]
Linn, S. C. [3 ]
Boogerd, W. [4 ,5 ]
Beex, L. V. A. M. [6 ]
Gundy, C. M. [1 ]
Nortier, J. W. R. [7 ]
van de Velde, C. J. H. [8 ]
van Dam, F. S. A. M. [1 ]
Schagen, S. B. [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands
[2] Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, Erasmus Med Ctr, NL-3008 AE Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands
[5] Slotervaart Med Ctr, Dept Neurol, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[7] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[8] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands
关键词
Breast cancer; Postmenopausal; Cognitive function; Neuropsychological testing; Psychological function; Adjuvant systemic treatment; REPRODUCTIVE PERIOD; CHEMOTHERAPY; RISK; IMPAIRMENT; WOMEN; DYSFUNCTION; DEMENTIA; PEOPLE;
D O I
10.1016/j.critrevonc.2009.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to identify medical and psychological predictors for cognitive performance of breast cancer (BC) patients before the start of adjuvant systemic treatment and to compare cognitive performance between BC patients and healthy controls adjusting for medical and psychological variables. Material: 205 postmenopausal BC patients underwent pre-treatment neuropsychological tests and provided medical and psychological data. 124 healthy controls underwent the same assessment. Results: 'Treatment for diabetes mellitus' and/or 'hypertension', 'less hours spent on cognitively stimulating activities', 'fewer days since surgery' and 'more reproductive years' were associated with worse cognitive performance in the BC patients, independent of age and IQ. Cognitive differences between BC patients and healthy controls could partly be explained by the evaluated variables. Conclusion: The results stress the need for adjustment for pre-treatment cognitive differences between study groups, and also indicate that further research into pre-treatment cognitive dysfunction is warranted. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 50 条
  • [41] Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?
    Stueber, Tanja
    Novopashenny, Igor
    Diessner, Joachim
    Bartmann, Catharina
    Stein, Roland
    Krockenberger, Mathias
    Haeusler, Sebastian
    Janni, Wolfgang
    Kreienberg, Rolf
    Blettner, Maria
    Woeckel, Achim
    Wischnewsky, Manfred
    ONCOLOGY, 2017, 92 (06) : 317 - 324
  • [42] Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients
    Arriola, Kimberly R. Jacob
    Mason, Tamara A.
    Bannon, Kari Ann
    Holmes, Carol
    Powell, Cecil Lamonte
    Horne, Kandra
    O'Regan, Ruth
    PATIENT EDUCATION AND COUNSELING, 2014, 95 (01) : 98 - 103
  • [43] Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer
    Amidi, A.
    Christensen, S.
    Mehlsen, M.
    Jensen, A. B.
    Pedersen, A. D.
    Zachariae, R.
    BRITISH JOURNAL OF CANCER, 2015, 113 (05) : 794 - 801
  • [44] Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study
    Menning, Sanne
    de Ruiter, Michiel B.
    Kieffer, Jacobien M.
    van Rentergem, Joost Agelink
    Veltman, Dick J.
    Fruijtier, Agnetha
    Oldenburg, Hester S. A.
    Boven, Epie
    van der Meij, Suzan
    Lustig, Vera
    Bos, Monique E. M.
    Boogerd, Willem
    Reneman, Liesbeth
    Schagen, Sanne B.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 52 (04) : 560 - +
  • [45] Factors correlated with fatigue in breast cancer patients before, during and after adjuvant chemotherapy: The FATSEIN study
    Rotonda, C.
    Guillemin, F.
    Bonnetain, F.
    Conroy, T.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (02) : 244 - 249
  • [46] Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality
    Vervoort, MM
    Draisma, G
    Fracheboud, J
    van de Poll-Franse, LV
    de Koning, HJ
    BRITISH JOURNAL OF CANCER, 2004, 91 (02) : 242 - 247
  • [47] Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
    Gass, Paul
    Fasching, Peter A.
    Fehm, Tanja
    de Waal, Johann
    Rezai, Mahdi
    Baier, Bernd
    Baake, Gerold
    Kolberg, Hans-Christian
    Guggenberger, Martin
    Warm, Mathias
    Harbeck, Nadia
    Wuerstlein, Rachel
    Deuker, Joerg-Uwe
    Dall, Peter
    Richter, Barbara
    Wachsmann, Grischa
    Brucker, Cosima
    Siebers, Jan W.
    Fersis, Nikos
    Kuhn, Thomas
    Wolf, Christopher
    Vollert, Hans-Walter
    Breitbach, Georg-Peter
    Janni, Wolfgang
    Landthaler, Robert
    Kohls, Andreas
    Rezek, Daniela
    Noesselt, Thomas
    Fischer, Gunnar
    Henschen, Stephan
    Praetz, Thomas
    Heyl, Volker
    Kuehn, Thorsten
    Krauss, Thomas
    Thomssen, Christoph
    Hohn, Andre
    Tesch, Hans
    Mundhenke, Christoph
    Hein, Alexander
    Rauh, Claudia
    Bayer, Christian M.
    Jacob, Adib
    Schmidt, Katja
    Belleville, Erik
    Hadji, Peymann
    Brucker, Sara Y.
    Beckmann, Matthias W.
    Wallwiener, Diethelm
    Kuemmel, Sherko
    Loehberg, Christian R.
    BREAST CARE, 2016, 11 (05) : 315 - 322
  • [48] Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality
    M M Vervoort
    G Draisma
    J Fracheboud
    L V van de Poll-Franse
    H J de Koning
    British Journal of Cancer, 2004, 91 : 242 - 247
  • [49] Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
    Ragusi, M. A. A.
    van der Velden, B. H. M.
    van Maaren, M. C.
    van der Wall, E.
    van Gils, C. H.
    Pijnappel, R. M.
    Gilhuijs, K. G. A.
    Elias, S. G.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (01) : 161 - 173
  • [50] Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study
    Diessner, Joachim
    Wischnewsky, Manfred
    Blettner, Maria
    Haeusler, Sebastian
    Janni, Wolfgang
    Kreienberg, Rolf
    Stein, Roland
    Stueber, Tanja
    Schwentner, Lukas
    Bartmann, Catharina
    Woeckel, Achim
    PLOS ONE, 2016, 11 (12):